In the present study, we generated the conditionally activated point mutation Fgfr2‐S252W that has also been observed in human breast cancer.[32, 33] We investigated the possible role of Fgfr2 activation in mammary tumor formation. The gene discussed is FGFR2; the disease is breast carcinoma.